Contact: Lauren Dart

Congresswoman Matsui Demands Answers on Affordability of EpiPen for Families
Washington, D.C.– Today, Congresswoman Doris Matsui (D-CA) sent a letter to Mylan Inc. CEO Heather Bresch expressing her concerns that the price increases for the EpiPen are preventing children and families from getting access to this lifesaving drug.
Congresswoman Matsui wrote, “For adults and children with severe allergies, an epinephrine injection can be the difference between life and death. No parent should have to make a decision between spending $600 on two EpiPens for a child and putting food on the table for their family.”
Since 2007, the price for the EpiPen has spiked over 400%, an increase that is not correlated with any new research on the drug.
Congresswoman Matsui is asking Mylan for an explanation on how they will ensure this life-saving product is accessible and affordable for families.
The full text of the letter can be found here.